Spastic Paraplegia Type 2 Overview
Learn About Spastic Paraplegia Type 2
Spastic paraplegia type 2 is part of a group of genetic disorders known as hereditary spastic paraplegias. These disorders are characterized by progressive muscle stiffness (spasticity) and the development of paralysis of the lower limbs (paraplegia). Hereditary spastic paraplegias are divided into two types: pure and complex. The pure types involve the lower limbs. The complex types involve the lower limbs and can also affect the upper limbs to a lesser degree; the structure or functioning of the brain; and the nerves connecting the brain and spinal cord to muscles and sensory cells that detect sensations such as touch, pain, heat, and sound (the peripheral nervous system). Spastic paraplegia type 2 can occur in either the pure or complex form.
Mutations in the PLP1 gene cause spastic paraplegia 2. The PLP1 gene provides instructions for producing proteolipid protein 1 and a modified version (isoform) of proteolipid protein 1, called DM20. Proteolipid protein 1 and DM20 are primarily located in the brain and spinal cord (central nervous system) and are the main proteins found in myelin, the fatty covering that insulates nerve fibers. A lack of proteolipid protein 1 and DM20 can cause a reduction in the formation of myelin (dysmyelination) which can impair nervous system function, resulting in the signs and symptoms of spastic paraplegia type 2.
The prevalence of all hereditary spastic paraplegias combined is estimated to be 2 to 6 in 100,000 people worldwide. Spastic paraplegia type 2 likely accounts for only a small percentage of all spastic paraplegia cases.
This condition is inherited in an X-linked recessive pattern. A condition is considered X-linked if the mutated gene that causes the disorder is located on the X chromosome, one of the two sex chromosomes. In males (who have only one X chromosome), one altered copy of the gene in each cell is sufficient to cause the condition. Because females have two copies of the X chromosome, one altered copy of the gene in each cell usually leads to less severe symptoms in females than in males, or may cause no symptoms at all. A characteristic of X-linked inheritance is that fathers cannot pass X-linked traits to their sons.
University Of Miami
Gemayaret Alvarez-Gonzalez is a Physiatrist in Miami, Florida. Dr. Alvarez-Gonzalez and is rated as an Experienced provider by MediFind in the treatment of Spastic Paraplegia Type 2. Her top areas of expertise are Hemiplegia, Developmental Expressive Language Disorder, Stroke, and Spastic Diplegia Infantile Type. Dr. Alvarez-Gonzalez is currently accepting new patients.
University Of Miami
Olimpia Carbunar is a Neurologist in Miami, Florida. Dr. Carbunar and is rated as an Experienced provider by MediFind in the treatment of Spastic Paraplegia Type 2. Her top areas of expertise are Inclusion Body Myositis, VEXAS Syndrome, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), and Benign Autosomal Dominant Myopathy. Dr. Carbunar is currently accepting new patients.
University Of Miami
Michael Benatar is a Neurologist in Miami, Florida. Dr. Benatar and is rated as an Experienced provider by MediFind in the treatment of Spastic Paraplegia Type 2. His top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Myasthenia Gravis, Frontotemporal Dementia, and Thymectomy. Dr. Benatar is currently accepting new patients.
Summary: The Registry and Natural History Study for Early Onset Hereditary Spastic Paraplegia (HSP) is focused on gathering longitudinal clinical data as well as biological samples (skin and/or blood and/or saliva) from male and female patients, under the age of 30, who exhibited early onset symptoms of HSP with (1) a clinical diagnosis of hereditary spastic paraplegia and (2) the presence of variants in H...
Published Date: March 01, 2008
Published By: National Institutes of Health